Document is current
Any future updates will be listed below
-
Authors
Rodrigues Lopes, Ines https://orcid.org/0000-0003-1527-543X
Alcantara, Laura Maria
Silva, Ricardo Jorge https://orcid.org/0000-0002-6313-5119
Josse, Jerome https://orcid.org/0000-0001-6780-9646
Vega, Elena Pedrero
Cabrerizo, Ana Marina
Bonhomme, Melanie
Lopez, Daniel https://orcid.org/0000-0002-8627-3813
Laurent, Frederic
Vandenesch, Francois https://orcid.org/0000-0001-9412-7106
Mano, Miguel https://orcid.org/0000-0003-1922-4824
Eulalio, Ana https://orcid.org/0000-0002-7355-0674
- License Information
-
More Information
Article History
Received: 4 August 2022
Accepted: 8 November 2022
First Online: 22 November 2022
Competing interests
: The authors declare no competing interests.
: The 93 <i>S. aureus</i> BJI isolates were passively collected in routine at Institute for Infectious Agents—Hospices Civils de Lyon. As no personal data were collected in the context of the present study, the use of the sole clinical isolates for research purposes requires no specific agreement from patients, according to the French health authorities. The 48 Ba and 50 IE <i>S. aureus</i> isolates were collected from the French national prospective multicenter cohort VIRSTA (LeMoing, 2015) registered in the European Clinical Trials Database (EUDRACT 169 2,008-A00680-55).
